Publication:
Consensus on Current Injectable Treatment Strategies in the Asian Face

dc.contributor.authorWoffles T.L. Wuen_US
dc.contributor.authorSteven Liewen_US
dc.contributor.authorHenry H. Chanen_US
dc.contributor.authorWilson W.S. Hoen_US
dc.contributor.authorNantapat Supapannacharten_US
dc.contributor.authorHong Ki Leeen_US
dc.contributor.authorAdri Prasetyoen_US
dc.contributor.authorJonathan Nevin Yuen_US
dc.contributor.authorJohn D. Rogersen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherThe University of Hong Kongen_US
dc.contributor.otherJY Dermatology and Aesthetic Centeren_US
dc.contributor.otherShape Clinicen_US
dc.contributor.otherWoffles Wu Aesthetic Surgery and Laser Centreen_US
dc.contributor.otherView Plastic Surgery Clinicen_US
dc.contributor.otherDivision of Plastic, Reconstructive and Aesthetic Surgeryen_US
dc.contributor.otherMedical Affairsen_US
dc.date.accessioned2020-10-05T05:52:46Z
dc.date.available2020-10-05T05:52:46Z
dc.date.issued2020-08-01en_US
dc.description.abstractBACKGROUND: The desire for and use of nonsurgical injectable esthetic facial treatments are increasing in Asia. The structural and anatomical features specific to the Asian face, and differences from Western populations in facial aging, necessitate unique esthetic treatment strategies, but published recommendations and clinical evidence for injectable treatments in Asians are scarce. METHODS: The Asian Facial Aesthetics Expert Consensus Group met to discuss current practices and consensus opinions on the cosmetic use of botulinum toxin and hyaluronic acid (HA) fillers, alone and in combination, for facial applications in Southeastern and Eastern Asians. Consensus opinions and statements on treatment aims and current practice were developed following discussions regarding pre-meeting and meeting survey outcomes, peer-reviewed literature, and the experts' clinical experience. RESULTS: The indications and patterns of use of injectable treatments vary among patients of different ages, and among Asian countries. The combination use of botulinum toxin and fillers increases as patients age. Treatment aims in Asians and current practice regarding the use of botulinum toxin and HA fillers in the upper, middle, and lower face of patients aged 18 to[55 years are presented. CONCLUSIONS: In younger Asian patients, addressing proportion and structural features and deficiencies are important to achieve desired esthetic outcomes. In older patients, maintaining facial structure and volume and addressing lines and folds are essential to reduce the appearance of aging. This paper provides guidance on treatment strategies to address the complex esthetic requirements in Asian patients of all ages. LEVEL OF EVIDENCE V: This journal requires that the authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .en_US
dc.identifier.citationAesthetic plastic surgery. Vol.44, No.4 (2020), 1195-1207en_US
dc.identifier.doi10.1007/s00266-020-01818-8en_US
dc.identifier.issn14325241en_US
dc.identifier.other2-s2.0-85089924104en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/59209
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089924104&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleConsensus on Current Injectable Treatment Strategies in the Asian Faceen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089924104&origin=inwarden_US

Files

Collections